Benzodiazepine receptor ligands and hepatic encephalopathy: further unfolding of the GABA story.
Jones
E A
EA
D000818:Animals; D001386:Azides / Q000494:pharmacology; D001569:Benzodiazepines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D001570:Benzodiazepinones / Q000494:pharmacology; D001921:Brain / Q000473:pathology / Q000503:physiopathology; D002490:Central Nervous System / Q000473:pathology / Q000503:physiopathology; D005442:Flumazenil / Q000494:pharmacology; D006501:Hepatic Encephalopathy / Q000378:metabolism* / Q000503:physiopathology; D006801:Humans; D008024:Ligands; D009474:Neurons / Q000502:physiology; D011963:Receptors, GABA-A / Q000378:metabolism* / Q000502:physiology; D009435:Synaptic Transmission / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D001386:Azides; D001570:Benzodiazepinones; D008024:Ligands; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D005442:Flumazenil; D005680:gamma-Aminobutyric Acid; C040725:Ro 15-3505; C042957:Ro 15-4513